Creatine for Treatment of Depression Associated With Type 2 Diabetes
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the administration of a widely available, naturally
occurring dietary supplement, creatine monohydrate, will reduce the severity of depression in
individuals with type 2 diabetes. The purpose of this study is to determine whether 12 weeks
of creatine supplementation is an effective treatment for depression in individuals with type
2 diabetes.